For adult patients with sepsis who have failed crystalloids or have serum albumin below 2.5 g/dL and are at risk for fluid overload, what do the guidelines recommend regarding albumin use, dosing (20% albumin 1–2 g/kg bolus followed by 0.5 g/kg/day), and monitoring parameters?

Albumin Use in Sepsis: Guideline Recommendations

Albumin should be considered as an adjunct to crystalloids in septic shock when patients require substantial amounts of crystalloids, but it is not recommended as a first-line resuscitation fluid or for the sole purpose of correcting low serum albumin levels.

Primary Recommendation

The 2017 Surviving Sepsis Campaign guidelines recommend crystalloids as the first-choice fluid for initial resuscitation and subsequent intravascular volume replacement in sepsis and septic shock (strong recommendation, moderate quality evidence) 111. Albumin may be added to crystalloids when patients require substantial amounts of crystalloids (weak recommendation, low quality evidence) 111.

When NOT to Use Albumin

The 2024 International Collaboration for Transfusion Medicine Guidelines explicitly recommend AGAINST using albumin in critically ill adults solely to increase serum albumin levels (conditional recommendation, very low certainty) 22. This is a critical distinction—low serum albumin alone is not an indication for albumin administration.

Practical Application Algorithm

Step 1: Initial Resuscitation

• Start with crystalloids (balanced crystalloids or saline)
• Target: minimum 30 mL/kg initial fluid challenge
• Continue crystalloid resuscitation as long as hemodynamic factors improve

Step 2: Consider Albumin Addition When:

• Patient requires "substantial amounts" of crystalloids (typically interpreted as >30-50 mL/kg or ongoing large volume requirements)
• Persistent hemodynamic instability despite adequate crystalloid resuscitation
• NOT based on serum albumin level alone

Step 3: Albumin Dosing (if used)

According to FDA labeling 33:

• 25% albumin is hyperoncotic and expands plasma volume 3-4 times the infused volume
• For hypovolemic shock: dose and rate adapted to individual response
• For hypoproteinemia: 50-75 g daily for adults, 25 g for children
• Rate limitation: Do not exceed 2 mL/min in hypoproteinemic patients to avoid circulatory overload 3

Critical Caveats and Pitfalls

Avoid These Common Errors:

1. Do not use albumin to "correct" a low albumin level 22. Hypoalbuminemia in sepsis reflects inflammation and capillary leak, not nutritional deficiency requiring replacement.

2. Monitor for fluid overload carefully 33. 25% albumin is hyperoncotic and requires adequate hydration or concurrent crystalloids 33.

3. Do not use albumin as monotherapy. It should supplement, not replace, crystalloid resuscitation 111.

4. Avoid in traumatic brain injury. Evidence suggests potential harm (RR 1.62 for mortality) 2.

Evidence Quality and Nuances

The recommendation for albumin in sepsis is weak with low-quality evidence 111. The largest trial (ALBIOS, 2014) showed no mortality benefit at 28 or 90 days when albumin was added to crystalloids in severe sepsis 4. However, albumin-treated patients achieved higher mean arterial pressure and lower net fluid balance 4.

Recent 2026 meta-analyses show conflicting results: One suggests a possible 10% mortality reduction (RR 0.90,95% CI 0.83-0.99) 5, while others show no mortality benefit 67. The 2024 ICTMG guidelines found no mortality benefit when crystalloids were compared with albumin (RR 1.02,95% CI 0.96-1.10) 2.

The Key Physiologic Consideration:

Albumin achieves better hemodynamic endpoints (higher MAP, lower fluid balance) but this does not translate to improved patient-centered outcomes (mortality, organ dysfunction) 28. This explains why guidelines support its use only as an adjunct when crystalloid requirements are excessive—to potentially reduce total fluid volume and associated complications.

Monitoring Parameters

When albumin is used 33:

• Hemodynamic response: MAP, heart rate, CVP
• Volume status: Watch for circulatory overload, pulmonary edema
• Fluid balance: Total input/output
• Renal function: Risk of AKI with hyperoncotic preparations in pre-existing renal impairment 6
• Do NOT target a specific serum albumin level 22

Bottom Line for Clinical Practice

Start with crystalloids, continue with crystalloids, and only add albumin when crystalloid volumes become excessive and hemodynamic instability persists. The specific threshold for "substantial amounts" is not defined but generally means >30-50 mL/kg or ongoing large requirements. Never use albumin simply because the serum albumin is low—this reflects the disease process, not a deficiency requiring correction 22.